Castle Creek Biosciences, Inc. and Pelthos Therapeutics
Pelthos Therapeutics to acquire Castle Creek Biosciences in a merger agreement.
Company-confirmed: reported in the company's own SEC filing
Latest update Oct 30, 2026, 9:17 AM ET
- ✓Announced
- 2Pending
- 3Completed
Acquirer
Pelthos TherapeuticsPTHSTarget
Castle Creek Biosciences, Inc.Not US-listed- Deal value
- Not disclosed
- the filing states none
- Offer
- Not disclosed
- Premium
- N/A
- Shown only for a signed all-cash price per share
- Expected close
- immediately prior to the Initial Effective Time
- merger
Share prices around the disclosure
Daily closes, each set to 100 on the first day shown. The dashed lines mark the session that first reflects each public event.